On the road to developing treatments for life-long disabilities

News

On the road to developing treatments for life-long disabilities

CMMT NEWS RELEASE
May 27th, 2011

Local researchers are finally on the road to developing targeted treatments for serious, life-long disabilities such as autism and schizophrenia, thanks to new genomics research focusing on abnormal brain development. With funding from Genome British Columbia, Dr. Daniel Goldowitz is opening the mysterious world of the developing brain by mapping the genes in the cerebellum and studying which genes influence abnormal development. Read more.


Share this:
Email

The Centre for Molecular Medicine and Therapeutics (CMMT) is a synergistic group of scientists and researchers who share a strong sense of commitment to solve the many genetic questions surrounding human illness and well being. Affiliated with the University of British Columbia and the Child & Family Research Institute, CMMT conducts discovery research and translates that research into effective clinical and therapeutic strategies to promote health. For more information, visit http://www.cmmt.ubc.ca/.

For more information, please contact Nicki Kahnamoui.